Anesthesia Considerations for Plaquenil (Hydroxychloroquine)
The primary anesthesia concern for patients on hydroxychloroquine is QT interval prolongation and the risk of serious cardiac arrhythmias, particularly when combined with other QT-prolonging drugs commonly used perioperatively.
Cardiac Monitoring and Drug Interactions
Mandatory ECG monitoring is essential throughout the perioperative period for patients on hydroxychloroquine 1. Hydroxychloroquine causes multiple cardiac adverse events, with significant QT prolongation being the most critical concern 1.
High-Risk Drug Combinations
Avoid or use extreme caution when combining hydroxychloroquine with:
- Halogenated anesthetics (sevoflurane, desflurane) - risk of cardiac toxicity 1
- Droperidol - additive/synergistic QT prolongation 1
- Ondansetron - additive QT prolongation 1
- Azithromycin - particularly dangerous combination with additive/synergistic QT prolongation 1
- Dexmedetomidine - risk of cardiac toxicity 1
- Haloperidol - risk of cardiac toxicity 1
- Tramadol - risk of cardiac toxicity 1
Environmental Factors
Hypothermia related to surgery and anesthesia may increase the risk of developing ventricular fibrillation in patients on hydroxychloroquine 1. Maintain normothermia aggressively throughout the perioperative period.
Safe Anesthetic Drug Choices
According to drug interaction data, hydroxychloroquine shows no significant interactions with 1:
- Remifentanil
- Cisatracurium
- Paracetamol (acetaminophen)
- Diclofenac
- Ibuprofen
- Heparin
- Oxazepam
- Most local anesthetics (bupivacaine, lidocaine)
- Propofol (though monitor for potential cardiac effects)
- Ketamine
- Fentanyl
- Morphine
Preoperative Assessment
Cardiac Evaluation
- Obtain baseline ECG focusing on QT interval measurement 2
- Review for pre-existing cardiac conduction abnormalities
- Document any history of cardiomyopathy (prolonged hydroxychloroquine therapy can cause toxic cardiomyopathy) 2
Neuromuscular Assessment
- Assess for proximal muscle weakness (hydroxychloroquine can cause toxic myopathy) 3
- Evaluate for peripheral neuropathy 3
- These toxicities are more common with concurrent renal failure 3
Renal Function
- Check renal function carefully - renal impairment increases risk of hydroxychloroquine toxicity 3
- Consider dose adjustments of renally cleared anesthetic drugs
Dosing Verification
- Confirm hydroxychloroquine dose is ≤5.0 mg/kg/day actual body weight (or ≤400 mg/day) 4, 5
- Higher doses significantly increase toxicity risk 4
Intraoperative Management
Monitoring Requirements
- Continuous ECG monitoring with QT interval assessment 1
- Standard ASA monitors (SpO2, NIBP, capnography) 6
- Consider processed EEG monitoring if using TIVA with neuromuscular blockade 6
- Maintain normothermia with active warming 1
Anesthetic Technique Selection
Regional anesthesia should be prioritized whenever feasible 1 to:
- Minimize exposure to potentially interacting systemic drugs
- Reduce cardiac stress
- Avoid QT-prolonging volatile anesthetics
If general anesthesia is required:
- Use remifentanil-based TIVA as first choice (no interaction) 1
- If using volatile agents, monitor carefully for arrhythmias 1
- Avoid droperidol and ondansetron for PONV prophylaxis 1
Common Pitfalls to Avoid
- Do not assume hydroxychloroquine is benign - it has significant cardiac toxicity potential 1, 2
- Do not combine multiple QT-prolonging drugs without careful risk-benefit assessment 1
- Do not overlook renal function - this dramatically increases toxicity risk 3
- Do not forget to maintain normothermia - hypothermia compounds arrhythmia risk 1
- Do not discontinue hydroxychloroquine perioperatively unless specifically indicated - sudden discontinuation may worsen underlying disease 2
Special Populations
Patients with Lupus or Rheumatoid Arthritis
- Continue hydroxychloroquine through the perioperative period 2
- Coordinate with rheumatology regarding corticosteroid coverage if applicable
- These patients may be on multiple immunosuppressants - check all drug interactions
Pregnancy
Hydroxychloroquine is considered safe during pregnancy (Pregnancy Category C) 2, but standard obstetric anesthesia precautions apply with heightened cardiac monitoring.
Emergency Considerations
In case of suspected hydroxychloroquine toxicity (rare but potentially fatal):
- Symptoms include cardiovascular collapse, bradycardia, arrhythmias, convulsions, hypoventilation 5, 7
- Diazepam administered parenterally may reverse cardiotoxicity 5
- Provide respiratory support and vasopressor therapy as needed 5, 7
- Consider dopamine, noradrenaline, or adrenaline for cardiovascular depression 7